
Optaloc0.5%
Popular Pharmaceuticals Ltd.
Betaxolol Hydrochloride is a cardioselective (beta-1 selective) adrenergic receptor blocking agent used in two distinct formulations for different, FDA-approved indications.
Betaxolol Hydrochloride is a cardioselective (beta-1 selective) adrenergic receptor blocking agent used in two distinct formulations for different, FDA-approved indications.
In glaucoma management, Betaxolol Hydrochloride ophthalmic solution is frequently used as adjunctive therapy when IOP is not adequately controlled by a single agent, and in hypertension the oral form is commonly added to a diuretic or other antihypertensive when monotherapy is insufficient.
Betaxolol Hydrochloride is not indicated for angle-closure glaucoma and does not have miotic properties needed to reverse angle closure.
| Population | Dose |
|---|---|
| Adults - initial | 10 mg of Betaxolol Hydrochloride orally once daily, alone or added to a diuretic |
| Adults - maintenance | If response is inadequate after 7-14 days, the dose may be increased to 20 mg once daily; doses above 20 mg once daily provide little additional effect |
| Elderly / renal impairment | Lower starting dose (e.g., 5 mg once daily) with slow titration; see Use in Special Populations |
| Pediatric | Safety and efficacy not established |
| Population | Dose |
|---|---|
| Adults | One drop of Betaxolol Hydrochloride ophthalmic solution (0.5%) or suspension (0.25%) in the affected eye(s) twice daily |
| Pediatric | Safety and efficacy not established |
Betaxolol Hydrochloride oral therapy should not be stopped abruptly (see Precautions and Warnings). Missed doses should be taken as soon as remembered unless the next dose is nearly due, in which case the missed dose should be skipped - do not double the dose.
Betaxolol Hydrochloride is contraindicated in patients with:
For the ophthalmic formulation, use is additionally contraindicated in patients with a history of bronchial asthma or severe chronic obstructive pulmonary disease, as some systemic absorption can occur even with topical ocular dosing.
Disclaimer
The information provided is accurate to the best of our knowledge, but it does not replace professional medical advice. We cannot guarantee its completeness or accuracy, and the absence of specific information about a drug should not be taken as an endorsement. We are not responsible for any consequences arising from this information, so please consult a healthcare professional for any concerns or questions.